Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy- Surgical Technique, Post-Operative Care, Expected Outcomes and Retreatment/Enhancements

T.M. Grippo*, M. Toteberg-Harms, M. Giovingo, B.A. Francis, R.R.M.P.C. de Crom, B. Jerkins, J.W. Brubaker, J. An, N. Radcliffe, R. Noecker

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Purpose: To provide expert consensus and evidence-based current guidelines on treatment technique, postoperative care, expected outcomes and retreatment for MicroPulse Transscleral Laser Treatment (TLT).Methods: A comprehensive search of PubMed led to the identification and analysis of 61 studies on MicroPulse TLT. To provide guidance in areas where there was not enough available literature, a three-round Delphi method was conducted involving 10 international experts in MicroPulse TLT.Results: The response rate was 70% in the first round, 70% in the second round, and 80% in the third round of the Delphi method. Once all responses were aggregated, a live meeting was held with 90% attendance, and consensus was achieved on each of the findings detailed in this manuscript.Conclusion: Used within appropriate treatment parameters, with proper technique and patient selection, MicroPulse TLT is a safe and effective treatment for many types and severities of glaucoma. MicroPulse TLT represents a useful addition to the glaucoma armamentarium.
Original languageEnglish
Pages (from-to)71-83
Number of pages13
JournalClinical Ophthalmology
Volume17
Issue number1
DOIs
Publication statusPublished - 2023

Keywords

  • glaucoma
  • MicroPulse
  • transscleral laser treatment
  • REFRACTORY GLAUCOMA
  • DIODE CYCLOPHOTOCOAGULATION
  • CLINICAL-OUTCOMES
  • SAFETY
  • CYCLOPHOTOTHERAPY
  • EFFICACY

Cite this